TY - JOUR
T1 - Murine models of infectious exacerbations of airway inflammation
AU - Starkey, Malcolm Ronald
AU - Jarnicki, Andrew Gregory
AU - Essilfie, Ama Tawiah
AU - Gellatly, Shaan Lae
AU - Kim, Richard Yong
AU - Brown, Alexandra Cerelina
AU - Foster, Paul Stephen
AU - Horvat, Jay Christopher
AU - Hansbro, Philip Michael
PY - 2013/6/1
Y1 - 2013/6/1
N2 - Airway inflammation underpins the pathogenesis of the major human chronic respiratory diseases. It is now well recognized that respiratory infections with bacteria and viruses are important in the induction, progression and exacerbation of these diseases. There are no effective therapies that prevent or reverse these events. The development and use of mouse models are proving valuable in understanding the role of infection in disease pathogenesis. They have recently been used to show that infections in early life alter immune responses and lung structure to increase asthma severity, and alter immune responses in later life to induce steroid resistance. Infection following smoke exposure or in experimental chronic obstructive pulmonary disease exacerbates inflammation and remodeling, and worsens cystic fibrosis. Further exploration of these models will facilitate the identification of new therapeutic approaches and the testing of new preventions and treatments.
AB - Airway inflammation underpins the pathogenesis of the major human chronic respiratory diseases. It is now well recognized that respiratory infections with bacteria and viruses are important in the induction, progression and exacerbation of these diseases. There are no effective therapies that prevent or reverse these events. The development and use of mouse models are proving valuable in understanding the role of infection in disease pathogenesis. They have recently been used to show that infections in early life alter immune responses and lung structure to increase asthma severity, and alter immune responses in later life to induce steroid resistance. Infection following smoke exposure or in experimental chronic obstructive pulmonary disease exacerbates inflammation and remodeling, and worsens cystic fibrosis. Further exploration of these models will facilitate the identification of new therapeutic approaches and the testing of new preventions and treatments.
UR - http://www.scopus.com/inward/record.url?scp=84879096032&partnerID=8YFLogxK
U2 - 10.1016/j.coph.2013.03.005
DO - 10.1016/j.coph.2013.03.005
M3 - Review Article
C2 - 23566696
AN - SCOPUS:84879096032
SN - 1471-4892
VL - 13
SP - 337
EP - 344
JO - Current Opinion in Pharmacology
JF - Current Opinion in Pharmacology
IS - 3
ER -